x
Filter:
Filters applied
- JTO: Editors Choice
- Besse, BenjaminRemove Besse, Benjamin filter
- Hendriks, Lizza ELRemove Hendriks, Lizza EL filter
Publication Date
Please choose a date range between 2019 and 2019.
Author
- Adam, Julien1
- Ammari, Samy1
- Auclin, Edouard1
- Audigier-Valette, Clarisse1
- Berghmans, Thierry1
- Botticella, Angela1
- Caramella, Caroline1
- Cousin, Sophie1
- Cufer, Tanja1
- Dingemans, Anne-Marie1
- Dingemans, Anne-Marie C1
- Dooms, Christophe1
- Duchemann, Boris1
- Dziadziuszko, Rafal1
- Edwards, John1
- Ekman, Simon1
- Faivre-Finn, Corinne1
- Ferrara, Roberto1
- Gaga, Mina1
- Gazzah, Anas1
- Giaj-Levra, Matteo1
- Giaj-Levra, Niccolò1
- Gietema, Hester1
Editors Choice
2 Results
- Original Article Non–Small Cell Lung CancerOpen Archive
Definition of Synchronous Oligometastatic Non–Small Cell Lung Cancer—A Consensus Report
Journal of Thoracic OncologyVol. 14Issue 12p2109–2119Published online: August 6, 2019- Anne-Marie C. Dingemans
- Lizza E.L. Hendriks
- Thierry Berghmans
- Antonin Levy
- Baktiar Hasan
- Corinne Faivre-Finn
- and others
Cited in Scopus: 130Improved outcome has been shown in patients with synchronous oligometastatic (sOM) NSCLC when treated with radical intent. As a uniform definition of sOM NSCLC is lacking, we developed a definition and diagnostic criteria by a consensus process. - Original Article Non–Small Cell Lung CancerOpen Archive
Outcome of Patients with Non–Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors
Journal of Thoracic OncologyVol. 14Issue 7p1244–1254Published online: February 16, 2019- Lizza E.L. Hendriks
- Clemence Henon
- Edouard Auclin
- Laura Mezquita
- Roberto Ferrara
- Clarisse Audigier-Valette
- and others
Cited in Scopus: 137Although frequent in NSCLC, patients with brain metastases (BMs) are often excluded from immune checkpoint inhibitor (ICI) trials. We evaluated BM outcome in a less-selected NSCLC cohort.